These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 3124964
1. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid. Casal M, Gutierrez J, González J, Ruiz P. Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964 [Abstract] [Full Text] [Related]
2. [Sensitivity of 7 mycobacterial species to new quinolones]. Gevaudan MJ, Mallet MN, Gulian C, Terriou P, Lagier P, de Micco P. Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429 [Abstract] [Full Text] [Related]
3. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Bhusal Y, Shiohira CM, Yamane N. Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578 [Abstract] [Full Text] [Related]
6. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus]. Zuccarelli M, Simeon de Buochberg M, Maillols M, Armynot du Chatelet AM, Attisso MA. Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422 [Abstract] [Full Text] [Related]
8. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria]. Saito H, Sato K, Tomioka H, Watanabe T. Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537 [No Abstract] [Full Text] [Related]
10. [Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin]. Cavuşoğlu C, Ciçek-Saydam C, Burhanoğlu D, Ozkalay N, Ozkaya D, Ozçam H, Bilgiç A. Mikrobiyol Bul; 2002 Jan; 36(1):118-23. PubMed ID: 12476777 [Abstract] [Full Text] [Related]
13. In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex. Johnson SM, Roberts GD. Diagn Microbiol Infect Dis; 1987 May; 7(1):89-91. PubMed ID: 3121243 [Abstract] [Full Text] [Related]
14. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China. Shi R, Zhang J, Otomo K, Zhang G, Sugawara I. Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128 [Abstract] [Full Text] [Related]
16. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae. Dhople AM, Ibanez MA, Gardner GD. Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790 [Abstract] [Full Text] [Related]
17. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar. Coban AY, Bilgin K, Uzun M, Tasdelen Fisgin N, Akgunes A, Cihan CC, Birinci A, Durupinar B. J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022 [Abstract] [Full Text] [Related]
19. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid. Steinbrück PW. Acta Tuberc Pneumol Belg; 1969 Apr; 60(3):413-6. PubMed ID: 4984421 [No Abstract] [Full Text] [Related]
20. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates. Periti P, Mazzei T, Nicoletti P. Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081 [Abstract] [Full Text] [Related] Page: [Next] [New Search]